Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Quality of life in patients surviving at least 12 months following high dose chemotherapy with autologous bone marrow support.

Quality of life in patients surviving at least 12 months following high dose chemotherapy with autologous bone marrow support. Psychooncology. 1999 Mar-Apr; 8(2):167-76.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.